Earlier concerns about surgery accelerating AMD progression likely overstated, researcher ...
Q4 2025 Earnings Call February 5, 2026 8:15 AM ESTCompany ParticipantsMaziar Doustdar - President, CEO & Member of ...
Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...